(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ARCEGEN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ARCEGEN

ST13

US500000079420059

Class

1, 5

Filing

79420059

Registration

8164061

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

19

Latest update

06/11/2026

Trademark type

Word

Nice classes

1, 5

Filing date

03/05/2025

Registration date

03/10/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/10/2026

Last transaction

06/11/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

CN

Examiner

COOK, RYAN ARMON

Law office

O80

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Yeasen Biotechnology (Shanghai) Co., Ltd

Representatives

Alex Patel Patel IP, P.C.

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Enzymes for use in protein hydrolysis; enzymes derived from biotechnological processes for use in industry; ferments for chemical purposesmilk ferments for industrial purposes; enzymes for industrial purposes; enzyme stabilizers; catalysts for use in the manufacture of industrial chemicals; biochemical catalysts; chemical preparations for scientific purposesother than for medical or veterinary use; chemical substances for analyses in laboratoriesother than for medical or veterinary purposes; enzyme preparations for the food industry

Class 5

Chemical reagents for medical or veterinary purposes; biological tissue cultures for medical purposes; diagnostic preparations for medical purposes; enzyme preparations for medical purposes; diagnostic biomarker reagents for medical purposes; chemical preparations for pharmaceutical purposesfor treatment of autoimmune diseases; chemical preparations for medical purposesfor treatment of autoimmune diseases; reagents for use in medical genetic testing; nutritional supplements; enzymes for veterinary purposes

Publications

History of USPTO decisions and trademark events.

19 publications found

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

06/10/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

03/10/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

03/10/2026

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/20/2026

PUBO

PUBLISHED FOR OPPOSITION

01/20/2026

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/14/2026

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/22/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/03/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/03/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/03/2025

RFNT

REFUSAL PROCESSED BY IB

10/18/2025

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

09/27/2025

RFRR

REFUSAL PROCESSED BY MPU

09/27/2025

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

08/16/2025

CNRT

NON-FINAL ACTION WRITTEN

08/15/2025

DOCK

ASSIGNED TO EXAMINER

08/06/2025

MAFR

APPLICATION FILING RECEIPT MAILED

03/28/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/28/2025

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

03/27/2025

Continuous trademark protection

Get notified about every new filing that threatens ARCEGEN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.